Moneycontrol PRO
HomeNewsBusinessStocksBuy Infosys: target of Rs 2050: Sharekhan

Buy Infosys: target of Rs 2050: Sharekhan

Sharekhan is bullish on Infosys has recommended buy rating on the stock with a target price of Rs 2050 in its research report dated October 13, 2021.

October 14, 2021 / 13:50 IST
HDFC Securities research report's outlook and valuations:  "The YTD EPS upgrades (consensus) have been led by mid-tiers such as Tata Elxis, Mindtree, Mastek, and Persistent Systems, ranging from 20-40 percent and, within tier 1, by Wipro (~15%). We expect the sector (coverage universe) to post 13 percent and 14.5 percent USD revenue/APAT CAGR over FY21-24E compared to 6.5/7.5 percent over the past five years. The mid-tier valuation premium relative to tier 1s may sustain, based on its relative outperformance (>500bps growth outperformance over FY21-24E as compared to 250bps earlier). We roll over valuations to Sepemtember-23E and increase target multiples for most of the companies in our coverage universe. We remain broadly constructive across the sector and ahead of consensus on growth/EPS; our preferred picks are Infosys, HCLT, Mphasis and Zensar."

HDFC Securities research report's outlook and valuations:  "The YTD EPS upgrades (consensus) have been led by mid-tiers such as Tata Elxis, Mindtree, Mastek, and Persistent Systems, ranging from 20-40 percent and, within tier 1, by Wipro (~15%). We expect the sector (coverage universe) to post 13 percent and 14.5 percent USD revenue/APAT CAGR over FY21-24E compared to 6.5/7.5 percent over the past five years. The mid-tier valuation premium relative to tier 1s may sustain, based on its relative outperformance (>500bps growth outperformance over FY21-24E as compared to 250bps earlier). We roll over valuations to Sepemtember-23E and increase target multiples for most of the companies in our coverage universe. We remain broadly constructive across the sector and ahead of consensus on growth/EPS; our preferred picks are Infosys, HCLT, Mphasis and Zensar."

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Infosys

Beat our estimates across financial parameters; Large deal TCVs declined 16% q-o-q, but management indicated that the deal pipeline remains strong; net headcount addition, client additions, and utilisation remained strong. Management has increased FY2022 CC revenue growth guidance to 16.5-17.5% from 14-16% earlier, broadly in-line with our expectations. EBIT margin guidance was maintained at 22-24%, as expected. Infosys is well placed to deliver industry-leading organic growth among large peers in the medium term, given broad-based demand, strong deal pipeline, and market share gains. Net profit to report a 15% CAGR over FY22-FY24E.

Outlook

We maintain Buy on Infosys with a revised PT of Rs. 2,050, given strong earnings growth potential, a robust deal pipeline, and strong demand.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Oct 14, 2021 01:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347